Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Honestly Tasty is a plant-based cheese company known for our award-winning products available in M&S, Ocado, and other stores. Our aim is to cater to cheese enthusiasts who either avoid dairy or are reducing their dairy intake. By combining innovative ideas with traditional cheese-making methods, we create alternatives that stand out and spark positive conversations among consumers.
days to go:
Expired
investment:
£307,067
Signature Brew strives to craft beer that enhances the musical experience. Since 2011, their mission has been to create more collaborative beers with bands and musicians than any other brand globally. Through the success of their flagship beers, Studio Lager and Roadie All-Night IPA, they aim to spread their vision of uniting people through exceptional beer, music, and memorable experiences on a national and international scale.
Continuing their original objective of improving the beer scene at beloved venues and festivals, Signature Brew remains committed to this ethos. Their direct-to-consumer customer base is expanding across the UK, driven by partnerships with artists and venues within their community. Operating from their cutting-edge brewery in East London, which includes an iconic live music venue, they consistently produce award-winning beer while fervently supporting grassroots music.
days to go:
Expired
investment:
£872,392
Loanpad is a financial technology entity that provides a user-friendly, lower-risk platform for investors to earn inflation-busting interest through shared short-term property loans. It argues that its portal shields customers from much of the risk of peer-to-peer (P2P) lending by partnering with established property lenders, who take on both higher risk and return. Investors can invest through Loanpad's Classic and/or Premium accounts (both ISA eligible). The Classic account pays 3% and allows daily withdrawals, while the Premium account pays 4% and requires a 60-day notice for withdrawals. Loanpad has over £22 million in funds under management, onboarded over 2,600 registered investors, and witnessed over 150% growth in loans through 2020. It is authorised by the Financial Conduct Authority (FCA). It will use the investment to boost marketing, further develop software capabilities, increase the size of its Interest Cover Fund (ICF), and invest in general working capital.
days to go:
Expired
investment:
£423,060
Hybrid Air Vehicles (HAV) is a company that is aiming to make air travel sustainable and carbon-free. It's product, Airlander, is the world’s first full-scale hybrid aircraft. By 2025, the company estimates that Airlander will fly with up to 90% fewer emissions than other aircraft. The market for Airlander technology is estimated at over US$ 50 billion over the next 20 years. HAV is focusing on securing launch orders for the production of Airlander 10, it's all-electric aircraft, from commercial and defence contractors. The company has featured in publications such as The Telegraph, Financial Times, BBC, GQ and Robb Report. HAV will use the investment to underpin its operations and contract discussions during Covid-19 recovery.
days to go:
Expired
investment:
£1,900,490
Cotswold Distillery creates quality craft sprits. Their distillery is vote the top attraction according to trip advisor; they have 3 tours a day, 7 days a week and approximately 30,000 visitors every year. They have created a single malt whiskey and premium gins both have won awards internationally.
They are looking for funding to build brand awareness and long term growth.
days to go:
Expired
investment:
£2,839,460
